Other Species / Isoforms
  RXRA (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
K4
____MDTKHFLPLDF
0 1
RXRA (human) ____MDTKHFLPLDF K4
RXRA (mouse) ____MDTkHFLPLDF K4-ub
RXRA (rat) ____MDTKHFLPLDF K4
S17-p
DFSTQVNsSLtsPTG
0 1
RXRA (human) DFSTQVNsSLtsPTG S17-p
RXRA (mouse) DFSTQVNSSSLNsPT S17
RXRA (rat) DFSTQVNSSSLSsPT S17
T20-p
TQVNsSLtsPTGRGs
0 1
RXRA (human) TQVNsSLtsPTGRGs T20-p
RXRA (mouse) QVNSSSLNsPTGRGS N21
RXRA (rat) QVNSSSLSsPTGRGS S21
S21-p
QVNsSLtsPTGRGsM
2 14
RXRA (human) QVNsSLtsPTGRGsM S21-p
RXRA (mouse) VNSSSLNsPTGRGSM S22-p
RXRA (rat) VNSSSLSsPTGRGSM S22-p
S27-p
tsPTGRGsMAAPsLH
Upstream
Downstream
1 0
Effects on Modified Protein
  • activity, inhibited
Effects on Biological Processes:
  • transcription, altered
Kinase, in vitro:
  • PKACA (human)
Putative in vivo kinases:
  • PKACA (human)
Treatment
  • cAMP_analog
RXRA (human) tsPTGRGsMAAPsLH S27-p
RXRA (mouse) NsPTGRGSMAVPSLH S28
RXRA (rat) SsPTGRGSMAAPSLH S28
S32-p
RGsMAAPsLHPSLGP
Upstream
Downstream
2 0
Effects on Modified Protein
  • activity, inhibited
  • molecular association, regulation
Effects on Biological Processes:
  • transcription, inhibited
Treatment
  • 1,25_dihydroxyvitamin_D
  • As2O3
RXRA (human) RGsMAAPsLHPSLGP S32-p
RXRA (mouse) RGSMAVPSLHPSLGP S33
RXRA (rat) RGSMAAPSLHPSLGP S33
S49-p
GSPGQLHsPISTLSS
Upstream
Downstream
2 0
Effects on Modified Protein
  • ubiquitination
Putative in vivo kinases:
  • GSK3B (human)
RXRA (human) GSPGQLHsPISTLSS S49-p
RXRA (mouse) GSPGQLHSPISTLSs S54
RXRA (rat) GSPGQLHSPISTLSS S54
S56
sPISTLSSPINGMGP
1 0
RXRA (human) sPISTLSSPINGMGP S56
RXRA (mouse) SPISTLSsPINGMGP S61-p
RXRA (rat) SPISTLSSPINGMGP S61
S66-p
NGMGPPFsVISSPMG
Upstream
Downstream
1 0
Effects on Modified Protein
  • ubiquitination
Putative in vivo kinases:
  • GSK3B (human)
RXRA (human) NGMGPPFsVISSPMG S66-p
RXRA (mouse) NGMGPPFSVISsPMG S71
RXRA (rat) NGMGPPFSVISSPMG S71
S70
PPFsVISSPMGPHSM
1 0
RXRA (human) PPFsVISSPMGPHSM S70
RXRA (mouse) PPFSVISsPMGPHSM S75-p
RXRA (rat) PPFSVISSPMGPHSM S75
S78-p
PMGPHSMsVPTtPTL
Upstream
Downstream
2 0
Effects on Modified Protein
  • ubiquitination
Putative in vivo kinases:
  • GSK3B (human)
RXRA (human) PMGPHSMsVPTtPTL S78-p
RXRA (mouse) PMGPHSMSVPTtPTL S83
RXRA (rat) PMGPHSMSVPTTPTL S83
T82-p
HSMsVPTtPTLGFST
Upstream
Downstream
3 0
Effects on Modified Protein
  • molecular association, regulation
Effects on Biological Processes:
  • transcription, inhibited
Treatment
  • 1,25_dihydroxyvitamin_D
RXRA (human) HSMsVPTtPTLGFST T82-p
RXRA (mouse) HSMSVPTtPTLGFGT T87-p
RXRA (rat) HSMSVPTTPTLGFET T87
K108-sm
VSSSEDIkPPLGLNG
2 1
RXRA (human) VSSSEDIkPPLGLNG K108-sm
RXRA (mouse) VSSTEDIkPPLGLNG K113-sm
RXRA (rat) VSSSEDIKPPLGLNG K113
S129-p
HPSGNMAsFTKHICA
0 1
RXRA (human) HPSGNMAsFTKHICA S129-p
RXRA (mouse) HPSGNMASFTKHICA S134
RXRA (rat) HPSGNMSSFTKHICA S134
Y150-p
SGKHYGVySCEGCKG
0 3
RXRA (human) SGKHYGVySCEGCKG Y150-p
RXRA (mouse) SGKHYGVYSCEGCKG Y155
RXRA (rat) SGKHYGVYSCEGCKG Y155
S225
NEVESTSSANEDMPV
0 1
RXRA (human) NEVESTSSANEDMPV S225
RXRA (mouse) NEVESTSsANEDMPV S230-p
RXRA (rat) NEVESTSSANEDMPV S230
Y249-p
VEPKTETyVEANMGL
Upstream
Downstream
2 0
Effects on Modified Protein
  • activity, inhibited
Effects on Biological Processes:
  • transcription, altered
  • transcription, inhibited
Kinase, in vitro:
  • MKK4 (human)
Treatment
  • 1,25_dihydroxyvitamin_D
RXRA (human) VEPKTETyVEANMGL Y249-p
RXRA (mouse) VEPKTETYVEANMGL Y254
RXRA (rat) VEPKTETYVEANMGL Y254
S259-p
ANMGLNPssPNDPVt
0 1
RXRA (human) ANMGLNPssPNDPVt S259-p
RXRA (mouse) ANMGLNPSsPNDPVT S264
RXRA (rat) ANMGLNPSSPNDPVT S264
S260-p
NMGLNPssPNDPVtN
Upstream
Downstream
10 1
Effects on Modified Protein
  • activity, inhibited
  • intracellular localization
  • molecular association, regulation
  • protein stabilization
Effects on Biological Processes:
  • transcription, altered
  • transcription, inhibited
Kinase, in vitro:
  • ERK1 (human)
  • ERK2 (human)
Putative in vivo kinases:
  • ERK1 (human)
  • ERK2 (human)
  • JNK1 (human)
  • JNK2 (human)
Treatment
  • 1,25_dihydroxyvitamin_D
  • culturing_of_cells
  • PD98059
  • retinoic_acid
RXRA (human) NMGLNPssPNDPVtN S260-p
RXRA (mouse) NMGLNPSsPNDPVTN S265-p
RXRA (rat) NMGLNPSSPNDPVTN S265
T266-p
ssPNDPVtNICQAAD
0 1
RXRA (human) ssPNDPVtNICQAAD T266-p
RXRA (mouse) SsPNDPVTNICQAAD T271
RXRA (rat) SSPNDPVTNICQAAD T271
K381
VLFNPDSKGLSNPAE
0 1
RXRA (human) VLFNPDSKGLSNPAE K381
RXRA (mouse) VLFNPDSkGLSNPAE K386-ub
RXRA (rat) VLFNPDSKGLSNPAE K386
Y397-p
EALREKVyASLEAyC
0 1
RXRA (human) EALREKVyASLEAyC Y397-p
RXRA (mouse) EALREKVYASLEAYC Y402
RXRA (rat) EALREKVYASLEAYC Y402
Y403-p
VyASLEAyCKHKYPE
0 1
RXRA (human) VyASLEAyCKHKYPE Y403-p
RXRA (mouse) VYASLEAYCKHKYPE Y408
RXRA (rat) VYASLEAYCKHKYPE Y408
K417-ub
EQPGRFAkLLLRLPA
0 4
RXRA (human) EQPGRFAkLLLRLPA K417-ub
RXRA (mouse) EQPGRFAkLLLRLPA K422-ub
RXRA (rat) EQPGRFAKLLLRLPA K422